PubRank

Te-Ling Lu

Author PubWeight™ 14.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2009 1.31
2 Individual and cumulative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the disease. Clin Chim Acta 2010 1.13
3 Polymorphisms inside microRNAs and microRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy. Clin Cancer Res 2010 1.13
4 Inhibition of cell migration by autophosphorylated mammalian sterile 20-like kinase 3 (MST3) involves paxillin and protein-tyrosine phosphatase-PEST. J Biol Chem 2006 1.01
5 Clinical significance of runt-related transcription factor 1 polymorphism in prostate cancer. BJU Int 2010 1.00
6 Opposing effects of beta-arrestin1 and beta-arrestin2 on activation and degradation of Src induced by protease-activated receptor 1. Cell Signal 2006 0.95
7 Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy. Int J Cancer 2011 0.91
8 Paclitaxel induces thrombomodulin downregulation in human aortic endothelial cells. Tex Heart Inst J 2011 0.83
9 Zinc ion acts as a cofactor for serine/threonine kinase MST3 and has a distinct role in autophosphorylation of MST3. J Inorg Biochem 2005 0.82
10 Antimicrobial, dehydroascorbate reductase, and monodehydroascorbate reductase activities of defensin from sweet potato [Ipomoea batatas (L.) Lam. 'Tainong 57'] storage roots. J Agric Food Chem 2008 0.81
11 Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients. Eur J Cancer 2013 0.81
12 Intercalated disc protein, mXinα, suppresses p120-catenin-induced branching phenotype via its interactions with p120-catenin and cortactin. Arch Biochem Biophys 2013 0.81
13 Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer. World J Urol 2011 0.81
14 Genetic variations in TP53 binding sites are predictors of clinical outcomes in prostate cancer patients. Arch Toxicol 2014 0.81
15 Clinical significance of tumor necrosis factor receptor superfamily member 11b polymorphism in prostate cancer. Ann Surg Oncol 2010 0.78
16 (-)-Epigallocatechin-3-gallate decreases thrombin/paclitaxel-induced endothelial tissue factor expression via the inhibition of c-Jun terminal NH2 kinase phosphorylation. Biochem Biophys Res Commun 2009 0.78
17 Multi-walled carbon nanotube composites with polyacrylate prepared for open-tubular capillary electrochromatography. Electrophoresis 2010 0.75
18 Ficusmicrochlorin A-C, two new methoxy lactone chlorins and an anhydride chlorin from the leaves of Ficus microcarpa. Chem Pharm Bull (Tokyo) 2011 0.75